,I1

ASSISTED

Inn

LIVING FOR SENIORS

Photo Credit: BlopMedica l

A

,
Farmington H i

BiopMedical's

cervical cancer
detection device

Faster Diagnosis

Israeli company's device helps find
cervical cancer quickly.

24-Hour Personal Care Staff 3 Delicious Meals Daily
Individually Tailored Care Plans
Medication Administration Bathing Assistance
Daily Housekeeping Weekly Laundry
Full Calendar of Activities Visiting Physician
Physical Therapy Services Satellite TV Free Wi-Fi
Single Story Building Backup Generator

David Shamah
I Times of Israel

A

Quality, Affordable Assisted Living
and Memory Care

All Services and Amenities include
at one low monthly • rice!

'Jr

Private Studios $2,820/month

Semi-Private $1,895/month

Call today
to schedule
a tour!

30350 W. 12 Mile Rd.,
Farmington Hills, Michigan 48334
248-851-9640
www.FarmingtonHillsInn.com

VA Benefits and Long Term Care Insurance Accepted
Locally owned and operated • Licensed by the State of Michigan

1962270

The Room Downstairs

A Feminine Boutique

STORE CLOSING SALE

Everything 1/2 OFF or Morel

After 9 years of serving our community, we are having a
HUGE STORE CLOSING SALE!
We carry women's and girl's clothing, size 5 girls through women's 20.

Fantastic Prizes will be awarded including an iPad Air and Keurig Coffee Maker.
Return this ad for bonus prize points. Store closes March 6th.

675 Coolidge Highway Berkley, MI 48072 - (248) 547-7900 - www.room-downstairs.com ,

Keep your company top of mind with our readers.

ADVERTISE WITH US! CALL 248.351.5107

Visit theJEWISHNEWS.com

52

February 26 • 2015

n Israeli medical device to
check for the presence of cervi-
cal cancer could be an impor-
tant factor in reducing the rate of death
from the disease in the developing world.
BiopMedical founder and CEO Ilan
Landesman believes that his examina-
tion device — the only one that provides
instant readings and results on whether a
woman is suffering from cervical cancer
— could be a boon to women every-
where, especially in places like Africa.
"The Biop device is perfect for any
setting, especially for doctors and nurses
in rural areas who don't have — and
can't afford — the fancy equipment usu-
ally needed to test for cervical cancer;
Landesman said. "It's a big-data solution
that can replace traditional methods of
examining for cervical cancer."
Cervical cancer is the fourth-biggest
cancer killer of women worldwide, but
where in the world a woman lives is a
very important factor in whether or not
she will survive the disease. As with so
many other major diseases, early detec-
tion is an important factor in cures. But
the vast majority of women in the world
do not have access to doctors to even
begin the process of checking for cervi-
cal cancer — much less the numerous
follow-up visits that are necessary.
Testing usually commences with a Pap
smear, which involves collecting cells
from the cervix for analysis. The cells
are collected using a speculum and sent
on for analysis, which could take several
weeks, even in a Western urban hospital.
If something suspicious is picked up
in the analysis, the patient will be asked
to undergo a colposcopy, a procedure
that provides an enlarged view of the
cervix. The results of the colposcopy are
then analyzed, which takes several more
weeks, at which point the patient may
undergo a biopsy or a pathological exam.
Not only is the procedure time-
consuming, said Landesman — it's also
not very accurate, as evidenced by the
many procedures needed to arrive at a

JN

final decision on whether or not cancer
is present.
The Biop device, which is basi-
cally a cloud-connected camera, pro-
vides a solution for just that scenario,
Landesman said. The Biop device is
inserted into the cervix and, using a
high-resolution optical system, sends
images to a remote server. There, the
images are analyzed in depth and com-
pared with a large library of images that
show the cancer in its various stages of
development.
Biop's software is then able to distin-
guish between normal and cancerous
cells, with the results returned a few
minutes later, so both the care provider
and the patient know what they are up
against — instead of waiting agonizing
weeks for answers. According to the
company, tests in clinics in the U.S. and
Europe show that the results are at least
90 percent accurate on the first test.
Biop uses IBM's Bluemix platform (the
company was a member of the recently
graduated first round of the IBM Alpha
Zone accelerator).
"Our system can translate the opti-
cal signature compared to the state of
the cervical tissue Landesman said. "It
identifies the correlation between the
optical signature and the state of the bio-
logical tissue and sends this information
to the IBM cloud environment, where a
unique algorithm is used for the analysis
process of the different phenomena, and
interpretation is received within min-
utes',' he continued.
"A database of raw data is formed and
becomes part of our cloud. IBM's unique
tools conduct advanced analysis of the
uploaded images and can even predict
future risks and recommend additional
tests; he said.
Last November, Biop was one of four
companies chosen as finalists in the
prestigious New Ventures Healthcare
Challenge sponsored by the Cleveland
Clinic, considered one of the top hospi-
tals in the U.S. The company came in a
close second in the contest, the judges
said, but they praised the Biop innova-
tion as a real breakthrough in cervical-
cancer diagnosis.

❑

